Search

Your search keyword '"Chatelain P"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Chatelain P" Remove constraint Author: "Chatelain P" Topic adenylyl cyclases Remove constraint Topic: adenylyl cyclases
28 results on '"Chatelain P"'

Search Results

1. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the beta-adrenoceptor and adenylate cyclase in rat heart.

2. Comparative effects of alpha-methyldopa, propranolol and hydralazine therapy on cardiac adenylate cyclase activity in normal and spontaneously hypertensive rats.

Catalog

Books, media, physical & digital resources

3. Impairment of hormone-stimulated cardiac adenylate cyclase activity in the genetically obese (fa/fa) Zucker rat.

4. Topographical distribution of the secretin- and VIP-stimulated adenylate cyclase system in the heart of five animal species.

5. Inhibition of forskolin-stimulated cardiac adenylate cyclase activity by short-chain alcohols.

6. Guanine nucleotide binding sites, responsible for adenylate cyclase activation and carbamylcholine binding inhibition, show similar properties in rat heart membranes.

7. The human heart beta-adrenergic receptors. II. Coupling of beta 2-adrenergic receptors with the adenylate cyclase system.

8. Comparison of beta-adrenergic receptors and the adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in the heart of spontaneously hypertensive rats.

9. Promotion by Mg2+ of guanosine 5'-(beta, gamma-imido) triphosphate activation of adenylate cyclase in rat lung and heart membranes.

10. The adenylate cyclase activity in heart membranes from normotensive and spontaneously hypertensive rats, after chemical sympathectomy, suggests the presence of presynaptic secretin receptors.

11. Low responsiveness of cardiac adenylate cyclase activity to peptide hormones in spontaneously hypertensive rats.

12. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.

13. Decreased secretin and glucagon responsiveness of adenylate cyclase in cardiac membranes from hypothyroid rats.

14. Presence of vasoactive intestinal peptide receptors coupled to adenylate cyclase in rat lung membranes.

15. Binding of vasoactive intestinal peptide and its stimulation of adenylate cyclase through two classes of receptors in rat liver membranes. Effects of 12 secretin analogues and 2 secretin fragments.

16. Modulation by n-alkanols of rat cardiac adenylate cyclase activity.

17. Thermodependence of basal and stimulated cardiac adenylate cyclase activity in normotensive and spontaneously hypertensive rats.

18. Heart receptors for VIP, PHI and secretin are able to activate adenylate cyclase and to mediate inotropic and chronotropic effects. Species variations and physiopathology.

19. Effects of PHI on vasoactive intestinal peptide receptors and adenylate cyclase activity in lung membranes. A comparison in man, rat, mouse and guinea pig.

20. Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.

21. Specific decrease of secretin/VIP-stimulated adenylate cyclase in the heart from the Lyon strain of hypertensive rats.

22. Selective alteration of secretin-stimulated cardiac adenylate cyclase activity in streptozotocin-diabetic rats.

23. Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase.

25. Effect of secretin, glucagon and vasoactive intestinal peptide on the hormone-sensitive rat cardiac adenylate cyclase [proceedings].

26. Characterization of the VIP- and secretin-stimulated adenylate cyclase system from human lung.

27. Early decrease in secretin-, glucagon-, and isoproterenol-stimulated cardiac adenylate cyclase activity in rats treated with isoproterenol.

28. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.